Vascular characterisation of triple negative breast carcinomas using dynamic MRI. (Q54618189)

1 June 2018

title

Vascular characterisation of triple negative breast carcinomas using dynamic MRI. (English)

1 reference

1 June 2018

2

Anwar R Padhani

1 reference

1 June 2018

author name string

Sonia P Li

1

1 reference

1 June 2018

N Jane Taylor

3

1 reference

1 June 2018

Mark J Beresford

4

1 reference

1 June 2018

Mei-Lin W Ah-See

5

1 reference

1 June 2018

J James Stirling

6

1 reference

1 June 2018

James A d'Arcy

7

1 reference

1 June 2018

David J Collins

8

1 reference

1 June 2018

Andreas Makris

9

1 reference

1 June 2018

language of work or name

English

0 references

publication date

22 January 2011

1 reference

1 June 2018

published in

European Radiology

1 reference

1 June 2018

volume

21

1 reference

1 June 2018

page(s)

1364-1373

1 reference

1 June 2018

issue

7

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s00330-011-2061-2

exact match

0 references

cites work

What is triple-negative breast cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative/basal-like breast cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative breast cancer: MRI features in 29 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Reproducibility of reference tissue quantification of dynamic contrast-enhanced data: comparison with a fixed vascular input function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative breast cancer--current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative breast cancer: correlation between imaging and pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative breast cancer: correlation between MR imaging and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Warburg revisited: imaging tumour blood flow and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple-negative breast cancer: role of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Microenvironmental and cellular consequences of altered blood flow in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Triple negative breast cancers: clinical and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2061-2

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

12 December 2020

Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer

1 reference

12 December 2020

Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model

1 reference

12 December 2020

The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer

1 reference

12 December 2020

Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging

1 reference

12 December 2020

10.1007/S00330-011-2061-2

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21258931

1 reference

1 June 2018